Drug Development

Felicity Thomas is the former Associate Editorial Director of Pharmaceutical Technology, Pharmaceutical Technology Europe, BioPharm International.

Articles

Easier access to information, targeting smaller patient populations, and increased regulatory focus on patient outcomes are driving patient‑centric drug development.

Patient‑Centric Drug Development Comes of Age

Flexibility and well considered manufacturing approaches could help tablet manufacturers face the increasing pressure resulting from the shifting bio/pharma development landscape.


Under Pressure

Kelly Boyer is general manager, Film Coatings at Colorcon Inc.

Market demand and regulatory guidance continues to promote improved medication design.


Gilding the Pill

Beverly Nickerson, PhD, is an associate research fellow in analytical research and development at Pfizer Inc., Eastern Point Road, Mail Stop 4086, Groton, CT 06340, tel. 860.441.0668, fax 860.715.8004, beverly_nickerson@groton.pfizer.com.

Anster Charles was a graduate student at the University of Missouri’s Chemistry Department, Columbia, MO.

Carlos Lee works for Lyndra Therapeutics, Watertown, MA.

Gail Johnson works for Pfizer Worldwide Research and Development in Groton, CT.

John Warzeka works for Pfizer Worldwide Research and Development in Groton, CT.

Laboratory testing found that a novel approach reduced the time required for sample preparation from hours to minutes. This article summarizes test methods and results.

Speeding Sample Preparation and API Extraction from Solid Oral Dosage Formulations

JÃ©rÃ´me Revel is senior development engineer at Recipharm.

Philippe Gorria is senior director of Pharmaceutical Development at Recipharm.

Modified-release oral dosage forms can offer benefits to both formulation scientists and patients.

Modified-Release Formulations: Improving Efficacy and Patient Compliance

Researchers at the Georgia Institute of Technology developed a technique for administering contraceptive hormones through ‘pharmaceutical jewelry’. 

Pharmaceutical Jewelry Could Offer a New Family Planning Approach

The organizers of Pharmapack Europe have revealed their prediction that the drug delivery and healthcare packaging industry will experience significant growth during 2019.

Pharmapack Europe Event Organizers Predict Sizeable Sector Growth Potential

Alcami Biologics formed to meet market demands for biological drug development services.

Alcami Announces Biologics Enterprise

Catalent announces investment for its Zydis ODT technology, offering increased drug load and taste-masking capabilities.

Catalent Invests in Zydis Ultra Commercialization

The company received $4.8 million from the Bill & Melinda Gates Foundation to accelerate global health research in the development of vaccines and antibody-based treatments for infectious diseases.

Formulation and Drug Delivery